Tat-CIAPIN1 protein prevents against cytokine-induced cytotoxicity in pancreatic RINm5F β-cells

키워드

참고문헌 (52)

1. Welters A, "Metabolism of human diseases:organ physiology and pathophysiology", pp.163~173 (2014), Springer
2. Katsarou A, "Type 1 diabetes mellitus", Nat Rev Dis Primers, 3, pp.17016~ (2017)
3. Lukic ML, "New insight into early events in type 1 diabetes : role for islet stem cell exosomes", Diabetes, 63, pp.835~837 (2014)
4. Patterson CC, "Trends in childhood type 1 diabetes incidence in Europe during 1989-2008 : evidence of non-uniformity over time in rates of increase", Diabetologia, 55, pp.2142~2147 (2012)
5. Patterson CC, "EURODIAB Study Group : incidence trends for childhood type 1 diabetes in Europe during 1989-2003and predicted new cases 2005-20 : a multicentre prospective registration study", Lancet, 373, pp.2027~2033 (2009)
6. Imai Y, "Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease", Diabetes Obes Metab, 15, pp.S117~S129 (2013)
7. Cnop M, "Mechanisms of pancreatic beta cell death in type 1 and type 2 diabetes : many differences, few similarities", Diabetes, 54, pp.S97~S107 (2005)
8. Corbett JA, "Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM", Diabetes, 41, pp.897~903 (1992)
9. Shibayama H, "Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis", J Exp Med, 199, pp.581~592 (2004)
10. Hao Z, "Subcellular localization of CIAPIN1", J Histochem Cytochem, 54, pp.1437~1444 (2006)
11. Zhang Y, "Inhibition of miR-182-5p protects cardiomyocytes from hypoxia-induced apoptosis by targeting CIAPIN1", Biochem Cell Biol, 96, pp.646~654 (2018)
12. Huang Z, "The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms", Eur Rev Med Pharmacol Sci, 21, pp.3054~3060 (2017)
13. Hao Z, "CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells", Cancer Biol Ther, 5, pp.261~266 (2006)
14. Li X, "CIAPIN1 as a therapeutic target in cancer", Expert Opin Ther Targets, 14, pp.603~610 (2010)
15. Li X, "Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA", Mol Biol, 42, pp.102~109 (2008)
16. Wang X, "Cytokine-induced apoptosis inhibitor 1 inhibits the growth and proliferation of multiple myeloma", Mol Med Res, 12, pp.2056~2062 (2015)
17. Park KA, "Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain", J Neural Transm, 118, pp.433~444 (2011)
18. Sethi G, "Multifaceted link between cancer and inflammation", Biosci Rep, 32, pp.1~15 (2012)
19. Sethi G, "Potential pharmacological control of the NF-kappaB pathway", Trends Pharmacol Sci, 30, pp.313~321 (2009)
20. Lemmon MA, "Cell signaling by receptor tyrosine kinases", Cell, 141, pp.1117~1134 (2010)
21. Gump JM, "TAT transduction : the molecular mechanism and therapeutic prospects", Trends Mol Med, 13, pp.443~448 (2007)
22. 문정일, "Enhanced delivery of protein fused to cell penetrating peptides to mammalian cells", BMB Reports, 52(5), pp.324~329 (2019), 생화학분자생물학회[DOI]
23. Frankel AD, "Cellular uptake of the tat protein from human immunodeficiency virus", Cell, 55, pp.1189~1193 (1988)
24. Kardani K, "Cell penetrating peptides : the potent multi-cargo intracellular carriers", Expert Opin Drug Deliv, 16, pp.1227~1258 (2019)
25. Lindsay MA, "Peptide-mediated cell delivery : application in protein target validation", Curr Opin Pharmacol, 2, pp.587~594 (2002)
26. Wadia JS, "Modulation of cellular function by TAT mediated transduction of full length proteins", Curr Protein Pept Sci, 4, pp.97~104 (2003)
27. Snyder EL, "Cell penetrating peptides in drug delivery", Pharm Res, 21, pp.389~393 (2004)
28. Yeo HJ, "Tat-CIAPIN1 inhibits hippocampal neuronal cell damage through the MAPK and apoptotic signaling pathways", Free Radic Biol Med, 135, pp.68~78 (2019)
29. 여현지, "Transduced Tat-CIAPIN1 reduces the inflammatory response on LPS- and TPA-induced damages", BMB Reports, 52(12), pp.695~699 (2019), 생화학분자생물학회[DOI]
30. van den Berg A, "Protein transduction domain delivery of therapeutic macromolecules", Curr Opin Biotechnol, 22, pp.888~893 (2011)
31. Dietz GP, "Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research", Curr Pharm Biotechnol, 11, pp.167~174 (2010)
32. 김대원, "Tat-ATOX1 inhibits inflammatory responses via regulation of MAPK and NF-κB pathways", BMB Reports, 51(12), pp.654~659 (2018), 생화학분자생물학회
33. Shin MJ, "Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury", Free Radic Biol Med, 67, pp.195~210 (2013)
34. Shin MJ, "Tat-PRAS40 prevent hippocampal HT-22 cell death and oxidative stress induced animal brain ischemic insults", Free Radic Biol Med, 97, pp.250~262 (2016)
35. 조수빈, "Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage", Experimental Neurobiology, 28(5), pp.612~627 (2019), 한국뇌신경과학회
36. Herbig ME, "Membrane surfaceassociated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides", Biophys J, 89, pp.4056~4066 (2005)
37. Wadia JS, "Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis", Nat Med, 10, pp.310~315 (2004)
38. El-Sayed A, "Delivery of macromolecules using arginine-rich cell-penetrating peptides : ways to overcome endosomal entrapment", AAPS J, 11, pp.13~22 (2009)
39. Frankel AD, "Tat protein from human immunodeficiency virus forms a metal-linked dimer", Science, 240, pp.70~73 (1988)
40. Lei XG, "Two tales of antioxidant enzymes on cells and diabetes", Antioxid Redox Signal, 14, pp.489~503 (2011)
41. Lenzen S, "Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues", Free Radic Biol Med, 20, pp.463~466 (1996)
42. Lundh M, "Small-molecule inhibition of inflammatory beta cell death", Diabetes Obes Metab, 15, pp.176~184 (2013)
43. Rabinovitch A, "Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus", Biochem Pharmacol, 55, pp.1139~1149 (1998)
44. Eldor R, "Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents", Proc Natl Acad Sci U S A, 103, pp.5072~5077 (2006)
45. Grey ST, "Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function", J Immunol, 170, pp.6250~6256 (2003)
46. Sakai N, "p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis", Nephrol Dial Transplant, 17, pp.998~1004 (2002)
47. Shi Y, "Protective and anti-angiopathy effects of ginsenoside Re against diabetes mellitus via the activation of p38MAPK, ERK1", 2 and JNK signaling, 2016, pp.14, 4849~4856
48. Zhang Y, "Lentinan protects pancreatic cells from STZ-induced damage", J Cell Mol Med, 20, pp.1803~1812 (2016)
49. Riedl SJ, "Molecular mechanisms of caspase regulation during apoptosis", Nat Rev Mol Cell Biol, 5, pp.897~907 (2004)
50. Reed JC, "Proapoptotic multidomain Bcl-2", Bax-family protein : mechanisms, physiological roles, and therapeutic opportunities, 2006, pp.13, 1378~1386
51. Zhang HJ, "Downregulation of miR-16 protects H9c2(2-1)cells against hypoxia", reoxygenation damage by targeting CIAPIN1 and regulation of NF-κB pathway, 2019, pp.20, 3113~3122
52. Bradford M, "A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding", Anal Biochem, 72, pp.248~254 (1976)

관련 논문AI추천